Innate Pharma unveils strategy to accelerate growth through focused cancer immunotherapy programs.

Innate Pharma, a biopharmaceutical company, has announced a new strategy aimed at accelerating its growth. The details of the new plan include focusing on key programs and partnerships to enhance its pipeline of cancer immunotherapy drugs. The company aims to streamline operations and allocate resources more effectively to boost its market presence and innovation.

3 months ago
3 Articles